KIF21B and Alzheimer disease: Therefore, we used NeuN (RBFOX3) as marker for neuron density and found a significant reduction in NeuN in the AD patients compared with NDC above 72 years of age (p = 0.006, Figure 2B), whereas no differences between these groups in kif21b expression were found (Figure 2A).